BioNexus Gene Lab Corp. Income Taxes Paid
BioNexus Gene Lab Corp. (BGLC) reported Income Taxes Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-14
- BioNexus Gene Lab Corp. income taxes paid, net for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- BioNexus Gene Lab Corp. income taxes paid, net for the quarter ending 2026-03-31 was $0.00.
- BioNexus Gene Lab Corp. income taxes paid, net for the quarter ending 2025-12-31 was -$154.00.
- BioNexus Gene Lab Corp. income taxes paid, net for the quarter ending 2025-09-30 was -$27.18K.
- BioNexus Gene Lab Corp. income taxes paid, net for fiscal 2025 was -$14.82K.
- BioNexus Gene Lab Corp. income taxes paid, net for fiscal 2024 was -$40.38K.
- BioNexus Gene Lab Corp. income taxes paid, net for fiscal 2023 was -$66.97K.
- BioNexus Gene Lab Corp. income taxes paid, net for fiscal 2022 was -$170.45K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 6 month as first filed | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 9 month as first filed | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | -$154.00 derived: sum of 3 quarters · filed 2026-08-14 | -$27.34K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | -$154.00 derived: sum of 2 quarters · filed 2026-05-15 | -$27.34K derived: sum of 3 quarters · filed 2026-05-15 | -$9.90K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$154.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$27.34K derived: sum of 2 quarters · filed 2026-04-14 | -$9.90K derived: sum of 3 quarters · filed 2026-08-14 | -$14.82K 10-K · filed 2026-04-14 | ||
| 2025-09-30 | -$27.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$9.74K derived: sum of 2 quarters · filed 2026-08-14 | -$14.67K 10-Q · filed 2025-11-14 | -$15.21K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $17.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $12.51K 10-Q · filed 2026-08-14 | -$12.51K 10-Q · filed 2025-08-18 | $11.98K derived: sum of 3 quarters · filed 2026-08-14 | -$1.09K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$4.92K 10-Q · filed 2026-05-15 | -$5.46K derived: sum of 2 quarters · filed 2026-05-15 | -$18.53K derived: sum of 3 quarters · filed 2026-05-15 | -$30.79K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$538.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$13.61K derived: sum of 2 quarters · filed 2026-04-14 | -$25.86K derived: sum of 3 quarters · filed 2026-04-14 | -$40.38K 10-K · filed 2026-04-14 | ||
| 2024-09-30 | -$13.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$25.32K derived: sum of 2 quarters · filed 2025-11-14 | -$39.84K 10-Q · filed 2025-11-14 | -$59.01K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$12.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$26.77K 10-Q · filed 2025-08-18 | -$45.94K derived: sum of 3 quarters · filed 2025-08-18 | -$63.11K derived: sum of 4 quarters · filed 2025-08-18 | ||
| 2024-03-31 | -$14.52K 10-Q · filed 2025-05-15 | -$33.68K derived: sum of 2 quarters · filed 2025-05-15 | -$50.85K derived: sum of 3 quarters · filed 2025-05-15 | -$69.05K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$19.16K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$36.34K derived: sum of 2 quarters · filed 2025-04-15 | -$54.53K derived: sum of 3 quarters · filed 2025-04-15 | -$66.97K 10-K · filed 2025-04-15 | ||
| 2023-09-30 | -$17.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | -$35.37K derived: sum of 2 quarters · filed 2024-11-15 | -$47.81K 10-Q · filed 2024-11-15 | $47.81K 10-Q/A · filed 2024-03-26 | -$341.85K derived: sum of 4 quarters · filed 2024-11-15 | |
| 2023-06-30 | -$18.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$30.64K 10-Q · filed 2024-08-14 | -$324.68K derived: sum of 3 quarters · filed 2024-08-14 | -$127.53K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$12.44K 10-Q · filed 2024-05-15 | -$306.48K derived: sum of 2 quarters · filed 2024-05-15 | -$109.34K derived: sum of 3 quarters · filed 2024-05-15 | -$140.94K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | -$294.05K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | -$96.90K derived: sum of 2 quarters · filed 2024-04-16 | -$128.50K derived: sum of 3 quarters · filed 2024-04-16 | -$170.45K 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $197.15K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $165.54K derived: sum of 2 quarters · filed 2024-03-26 | $123.60K 10-Q/A · filed 2024-03-26 | -$123.60K 10-Q · filed 2022-11-14 | -$8.80K derived: sum of 4 quarters · filed 2024-03-26 | |
| 2022-06-30 | -$31.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$73.55K 10-Q · filed 2023-08-16 | $73.55K 10-Q · filed 2022-08-15 | -$205.94K derived: sum of 3 quarters · filed 2023-08-16 | -$344.57K derived: sum of 4 quarters · filed 2023-08-16 | |
| 2022-03-31 | -$41.95K 10-Q · filed 2023-05-09 | -$174.34K derived: sum of 2 quarters · filed 2023-05-09 | -$312.96K derived: sum of 3 quarters · filed 2023-05-09 | -$232.28K derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$132.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$271.02K derived: sum of 2 quarters · filed 2023-03-31 | -$190.33K derived: sum of 3 quarters · filed 2023-03-31 | -$226.77K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$138.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$57.94K derived: sum of 2 quarters · filed 2022-11-14 | -$94.37K 10-Q · filed 2022-11-14 | -$155.52K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $80.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $44.25K 10-Q · filed 2022-08-15 | -$44.25K 10-Q · filed 2021-08-12 | -$16.90K derived: sum of 3 quarters · filed 2022-08-15 | -$54.56K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$36.44K 10-Q · filed 2022-05-16 | -$97.59K derived: sum of 2 quarters · filed 2022-05-16 | -$135.25K derived: sum of 3 quarters · filed 2022-05-16 | -$179.75K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$61.15K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | -$98.81K derived: sum of 2 quarters · filed 2022-04-06 | -$143.31K derived: sum of 3 quarters · filed 2022-04-06 | -$143.50K 10-K · filed 2022-04-06 | ||
| 2020-09-30 | -$37.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$82.17K derived: sum of 2 quarters · filed 2021-11-15 | -$82.35K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | -$44.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$44.68K 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | -$183.00 10-Q · filed 2020-05-08 | |||||
| 2019-12-31 | -$10.71K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |